Aug 2026
Discovery of β-carboline derivatives as potent STAT3 dual phosphorylation inhibitor for hepatocellular carcinoma treatment.
Results indicate compound 18 as a promising STAT3 dual phosphorylation inhibitor for HCC treatment, designed and synthesized via structural modification of the β-carboline scaffold.
Ziqing Jian, Lanyi Wei, Meilin Ren et al.
· European journal of medicina... · 0 citations